Purple Innovation, Inc. — FY2020 Form 10-K
Reporting period: Fiscal year ended December 31, 2020. The filing provides annual results; the supplied text does not provide a clear standalone fourth-quarter income statement or cash flow, so figures below are full-year unless otherwise stated.
Business context
Purple designs and sells premium comfort products, including mattresses, pillows and cushions, using its proprietary Hyper-Elastic Polymer technology. Sales are made through direct-to-consumer (DTC) channels—including online and company showrooms—and wholesale partners. In 2020, DTC represented 74.8% of revenue and wholesale 25.2%; bedding represented 92.2%.
Financial results and liquidity
| Metric | FY2020 | FY2019 |
|---|---|---|
| Net revenue | $648.5 million | $428.4 million |
| Gross profit / margin | $305.1 million / 47.0% | $189.0 million / 44.1% |
| Operating income / margin | $71.2 million / 11.0% | $16.2 million / 3.8% |
| Consolidated net income (loss) | $10.9 million | $(12.4) million |
| Net income (loss) attributable to Purple Innovation, Inc. | $3.8 million | $(4.0) million |
| Operating cash flow | $81.3 million | $22.9 million |
| Cash and cash equivalents at year-end | $123.0 million | $33.5 million |
| Working capital at year-end | $96.9 million | $27.3 million |
- Revenue rose 51.4%. DTC revenue increased 83.0% to $485.3 million; wholesale revenue was essentially unchanged at $163.2 million.
- Cost of revenue increased 43.4% to $343.4 million. Gross-margin improvement reflected a greater DTC sales mix, as well as operating efficiencies.
- Marketing and sales expense increased to $188.0 million, but declined to 29.0% of revenue from 33.1%. Advertising expense was $130.3 million.
- Investing cash outflow was $39.1 million, including $27.9 million for property and equipment. Financing cash inflow was $47.4 million; cash increased $89.5 million during the year.
- Debt was $44.4 million under the new term loan at year-end; the $55 million revolving facility had no borrowings outstanding. The company reported covenant compliance.
Material changes and unusual items
- Purple refinanced and repaid its related-party borrowing in September, paying $45.0 million including accrued and paid-in-kind interest and a prepayment fee. The replacement credit agreement provides a $45 million term loan and $55 million revolver, with a five-year term.
- A $59.4 million noncash loss from remeasurement of liability warrants was recorded before the warrants were exercised for 2.6 million Class A shares. The warrants’ exercise price had been reduced to zero under their terms.
- The company recorded $34.2 million of tax receivable agreement (TRA) expense. Its total TRA liability was approximately $172.0 million, including $6.5 million classified as current. Under the agreement, Purple generally pays InnoHold 80% of specified realized tax benefits.
- A $43.7 million income tax benefit largely reflected a $35.5 million release of valuation allowances and recognition of deferred tax assets. This contributed to reported consolidated net income despite a $32.9 million pretax loss.
- Net income attributable to noncontrolling interests was $7.1 million. Nearly all Purple LLC units had been exchanged by year-end, leaving approximately 1% noncontrolling ownership.
Outlook, risks and contingencies
- No numerical full-year 2021 guidance is provided in the supplied filing text. Management said, subject to assumptions about the pandemic and business conditions, available cash, operating cash generation, revolver availability and channel recovery were expected to cover working capital and anticipated capital expenditures for the next 12 months.
- The 520,000-square-foot Georgia manufacturing facility began operations on March 3, 2021; Purple planned to ramp during 2021 to four Mattress Max machines and intended to hire more than 360 employees. The company also planned further showroom expansion.
- COVID-19 supported strong DTC demand but disrupted wholesale sales in the second quarter, and the company reported supplier constraints and delivery delays. Management cautioned that demand, restrictions and economic conditions remained uncertain.
- Key operating risks include scaling production and staffing, reliance on certain suppliers and specialized machinery, shipping capacity, intense competition and marketing costs, customer demand shifts, and dependence on wholesale and consumer-financing partners. Credit-facility covenants constrain capital spending, debt, distributions and other actions.
- Material legal matters include disputes with ReST and Intellibed, a Canadian trademark and copyright action, and a claim seeking approximately $7 million of Section 301 duty refunds. Outcomes are uncertain; the filing does not quantify a probable loss for these matters.
- The filing reports an unqualified audit opinion and effective disclosure and internal financial reporting controls at year-end. A previously reported material weakness in tax-provision controls was stated to have been remediated.
Most important facts for investors to verify
- Whether DTC growth and the unusually favorable 2020 demand environment persist, and whether wholesale sales recover without weakening margins.
- Whether the Georgia facility reaches planned capacity on schedule and whether added manufacturing, labor and delivery costs are absorbed efficiently.
- The cash-flow and liquidity impact of the $172.0 million TRA liability, including payment timing, tax-benefit realization assumptions and possible acceleration provisions.
- The debt balance, borrowing availability, covenant headroom and capital expenditure limits under the 2020 Credit Agreement.
- The effects of warrant-related dilution and other share issuance; the filing reports 63.9 million Class A shares outstanding at year-end and further warrant exercises after year-end.
- Developments in the disclosed litigation, the duty-refund claim, and any related-party or intellectual-property matters that could affect costs, royalties or competitive rights.